Plandai Biotechnology Operating Income

Plandai Biotechnology (PLPL) currently reports a operating income of $-62K as of March 2026. That compares with $-3.6M in the prior-year period — up 98.3% year over year. Use the charts on this page to explore Plandai Biotechnology's operating income history and peer comparisons.

Plandai Biotechnology's operating income increased from $-3.6M to $-62K — a 98.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Plandai Biotechnology reported $-62K in operating income as of March 2026. That compares with $-3.6M in the prior-year period — up 98.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-62K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Plandai Biotechnology, and consider following PLPL for alerts when major investors trade the stock.

Plandai Biotechnology is classified in the Healthcare sector. On operating income, it currently shows $-62K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLPL with unrelated industries.